Anifrolumab

ATC L04AG11 · 8 markets · 15 records

Anifrolumab 8 markets · 15 records Forms

AU 4 records · 4 strengths

300 mg/2 mLinjectionSAPHNELO also in US
300 mginjectionSAPHNELO anifrolumab 300 mg concentrated injection vial also in ES unknown
120 mginjectionSAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen also in ES unknown

Records without a stated strength · 1 SAPHNELO

US 2 records · 2 strengths

300 mg/2 mLinjectionSAPHNELO also in AU
120 mg/0.8 mLinjectionSAPHNELO

CA 2 records · 2 strengths

150 mgliquidSAPHNELO
120 mgliquidSAPHNELO

ES 2 records · 2 strengths

300 mginjectionSAPHNELO also in AU
120 mginjectionSAPHNELO PRECARGADA also in AU

MX 2 records · 1 strengths

Records without a stated strength · 1 SAPHNELO、SAPHNELO SC

TW 1 records · 1 strengths

150 mginjectionSAPHNELO 150 mg/ml Concentrate for Solution for Infusion+1莎芙諾注射劑 150毫克/毫升

HK 1 records · 1 strengths

Records without a stated strength · 1 SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/2ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 SAPHNELO

Side-by-side table

Strength / form / release	US	CA	AU	ES	MX	TW	HK	EU
300 mg/2 mL injection	SAPHNELO	not recorded	SAPHNELO	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	SAPHNELO anifrolumab 300 mg concentrated injection vial	SAPHNELO	not recorded	not recorded	not recorded	not recorded
150 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	SAPHNELO 150 mg/ml Concentrate for Solution for Infusion 莎芙諾注射劑 150毫克/毫升	not recorded	not recorded
120 mg injection	not recorded	not recorded	SAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen	SAPHNELO PRECARGADA	not recorded	not recorded	not recorded	not recorded
150 mg liquid	not recorded	SAPHNELO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
120 mg liquid	not recorded	SAPHNELO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
120 mg/0.8 mL injection	SAPHNELO	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	SAPHNELO	not recorded	not recorded	not recorded	SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/2ML	SAPHNELO
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	SAPHNELO SAPHNELO SC	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in MX · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX · TW 有记录（未在本表显示）。另有 2 個規格/劑型僅在 MX · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.